27320863|t|Alleviation of hepatic fat accumulation by betaine involves reduction of homocysteine via up-regulation of betaine-homocysteine methyltransferase (BHMT)
27320863|a|We investigated the anti-lipogenic effect of betaine in rats fed methionine and choline - deficient diet (MCD). Intake of MCD for 3 wk resulted in a significant accumulation of hepatic lipids, which was prevented by betaine supplementation in drinking water (1%). Phosphorylation of AMP-activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC), sterol regulatory element-binding protein 1c (SREBP-1c), and liver kinase B1 (LKB1) was inhibited by MCD intake, and these changes were all inhibited by betaine feeding. Meanwhile, betaine supplementation reversed the reduction of methionine and S-adenosylmethionine (SAM), and the elevation of homocysteine levels in the liver, which could be attributable to the induction of betaine-homocysteine methyltransfease (BHMT) and methionine adenosyltransferase (MAT). Different cell lines were used to clarify the role of homocysteine on activation of the AMPK pathway. Homocysteine treatment decreased pAMPK, pACC, pSREBP-1c and pLKB1 in HepG2 cells. Metformin - induced activation of AMPK was also inhibited by homocysteine. Treatment with hydroxylamine, a cystathionine β-synthase inhibitor, resulted in a reduction of pAMPK, pACC and pSREBP-1c, accompanied by an elevation of intracellular homocysteine. Betaine treatment prevented the homocysteine - induced reduction of pAMPK, pACC, pSREBP-1c and pLKB1 in H4IIE cells, but not in HepG2 cells. Also the elevation of cellular homocysteine and inhibition of protein expression of BHMT were prevented by betaine only in H4IIE cells which express BHMT. The results suggest that the beneficial effect of betaine against hepatic lipid accumulation may be attributed, at least in part, to the depletion of homocysteine via up-regulation of BHMT in hepatocytes.
27320863	0	11	Alleviation	T080	C0392756
27320863	15	22	hepatic	T029	C0205054
27320863	23	39	fat accumulation	T033	C0333574
27320863	43	50	betaine	T109,T121	C0005304
27320863	60	69	reduction	T080	C0392756
27320863	73	85	homocysteine	T116,T123	C0019878
27320863	90	103	up-regulation	T044	C0041904
27320863	107	145	betaine-homocysteine methyltransferase	T116,T126	C0053518
27320863	147	151	BHMT	T116,T126	C0053518
27320863	156	168	investigated	T169	C1292732
27320863	173	194	anti-lipogenic effect	T169	C0205245
27320863	198	205	betaine	T109,T121	C0005304
27320863	209	213	rats	T015	C0086893
27320863	218	228	methionine	T116,T121,T123	C0025646
27320863	233	240	choline	T109,T121,T123	C0008405
27320863	243	252	deficient	T080	C0332268
27320863	253	257	diet	T168	C0012155
27320863	259	262	MCD	T168	C0012155
27320863	275	278	MCD	T168	C0012155
27320863	302	313	significant	T078	C0750502
27320863	314	326	accumulation	T033	C0333574
27320863	330	337	hepatic	T029	C0205054
27320863	338	344	lipids	T109	C0023779
27320863	356	365	prevented	T080	C2700409
27320863	369	376	betaine	T109,T121	C0005304
27320863	377	392	supplementation	T061	C0242297
27320863	396	410	drinking water	T167	C0599638
27320863	417	432	Phosphorylation	T044	C1158886
27320863	436	464	AMP-activated protein kinase	T116,T126	C2350345
27320863	466	470	AMPK	T116,T126	C2350345
27320863	473	495	acetyl-CoA carboxylase	T116,T126	C0001022
27320863	497	500	ACC	T116,T126	C0001022
27320863	503	547	sterol regulatory element-binding protein 1c	T116,T123	C0537474
27320863	549	557	SREBP-1c	T116,T123	C0537474
27320863	564	579	liver kinase B1	T116,T126	C1431123
27320863	581	585	LKB1	T116,T126	C1431123
27320863	591	600	inhibited	T080	C0311403
27320863	604	607	MCD	T168	C0012155
27320863	608	614	intake	T169	C1512806
27320863	643	652	inhibited	T080	C0311403
27320863	656	663	betaine	T109,T121	C0005304
27320863	664	671	feeding	T058	C3714845
27320863	684	691	betaine	T109,T121	C0005304
27320863	692	707	supplementation	T061	C0242297
27320863	708	716	reversed	T169	C1555029
27320863	721	730	reduction	T080	C0392756
27320863	734	769	methionine and S-adenosylmethionine	T044	C1325080
27320863	771	774	SAM	T044	C1325080
27320863	785	794	elevation	T080	C3163633
27320863	798	817	homocysteine levels	T059	C2242817
27320863	825	831	liver,	T023	C0023884
27320863	867	876	induction	T045	C0014431
27320863	880	917	betaine-homocysteine methyltransfease	T116,T126	C0053518
27320863	919	923	BHMT	T116,T126	C0053518
27320863	929	959	methionine adenosyltransferase	T116,T126	C0025647
27320863	961	964	MAT	T116,T126	C0025647
27320863	967	976	Different	T080	C1705242
27320863	977	987	cell lines	T025	C0007634
27320863	1021	1033	homocysteine	T116,T123	C0019878
27320863	1037	1047	activation	T044	C0014429
27320863	1055	1059	AMPK	T116,T126	C2350345
27320863	1060	1067	pathway	T044	C0598390
27320863	1069	1081	Homocysteine	T116,T123	C0019878
27320863	1082	1091	treatment	T169	C1522326
27320863	1092	1101	decreased	T081	C0205216
27320863	1102	1107	pAMPK	T116,T126	C2350345
27320863	1109	1113	pACC	T116,T126	C0001022
27320863	1115	1124	pSREBP-1c	T116,T123	C0537474
27320863	1129	1134	pLKB1	T116,T126	C1431123
27320863	1138	1149	HepG2 cells	T025	C2717940
27320863	1151	1160	Metformin	T109,T121	C0025598
27320863	1163	1170	induced	T169	C0205263
27320863	1171	1181	activation	T044	C0014429
27320863	1185	1189	AMPK	T116,T126	C2350345
27320863	1199	1208	inhibited	T080	C0311403
27320863	1212	1224	homocysteine	T116,T123	C0019878
27320863	1226	1235	Treatment	T169	C1522326
27320863	1241	1254	hydroxylamine	T197	C0020362
27320863	1258	1282	cystathionine β-synthase	T116,T126	C0010641
27320863	1283	1292	inhibitor	T121	C0014432
27320863	1308	1317	reduction	T080	C0392756
27320863	1321	1326	pAMPK	T116,T126	C2350345
27320863	1328	1332	pACC	T116,T126	C0001022
27320863	1337	1346	pSREBP-1c	T116,T123	C0537474
27320863	1366	1375	elevation	T080	C3163633
27320863	1379	1392	intracellular	T082	C0178719
27320863	1393	1405	homocysteine	T116,T123	C0019878
27320863	1407	1414	Betaine	T109,T121	C0005304
27320863	1415	1424	treatment	T061	C0087111
27320863	1425	1434	prevented	T080	C2700409
27320863	1439	1451	homocysteine	T116,T123	C0019878
27320863	1454	1461	induced	T169	C0205263
27320863	1462	1471	reduction	T080	C0392756
27320863	1475	1480	pAMPK	T116,T126	C2350345
27320863	1482	1486	pACC	T116,T126	C0001022
27320863	1488	1497	pSREBP-1c	T116,T123	C0537474
27320863	1502	1507	pLKB1	T116,T126	C1431123
27320863	1511	1522	H4IIE cells	T025	C0007634
27320863	1535	1546	HepG2 cells	T025	C2717940
27320863	1557	1566	elevation	T080	C3163633
27320863	1579	1591	homocysteine	T116,T123	C0019878
27320863	1596	1606	inhibition	T052	C3463820
27320863	1610	1628	protein expression	T045	C1171362
27320863	1632	1636	BHMT	T116,T126	C0053518
27320863	1642	1651	prevented	T080	C2700409
27320863	1655	1662	betaine	T109,T121	C0005304
27320863	1671	1682	H4IIE cells	T025	C0007634
27320863	1689	1696	express	T045	C1171362
27320863	1697	1701	BHMT	T116,T126	C0053518
27320863	1753	1760	betaine	T109,T121	C0005304
27320863	1769	1776	hepatic	T029	C0205054
27320863	1777	1782	lipid	T109	C0023779
27320863	1783	1795	accumulation	T033	C0333574
27320863	1803	1813	attributed	T078	C0449234
27320863	1840	1849	depletion	T169	C0333668
27320863	1853	1865	homocysteine	T116,T123	C0019878
27320863	1870	1883	up-regulation	T044	C0041904
27320863	1887	1891	BHMT	T116,T126	C0053518
27320863	1895	1906	hepatocytes	T025	C0227525